Role of bisphosphonates in prostate cancer bone metastases.
about
Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formationZoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis.Bisphosphonates and bone metastases: current status and future directions.The role of the bone microenvironment in skeletal metastasis.
P2860
Role of bisphosphonates in prostate cancer bone metastases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of bisphosphonates in prostate cancer bone metastases.
@ast
Role of bisphosphonates in prostate cancer bone metastases.
@en
type
label
Role of bisphosphonates in prostate cancer bone metastases.
@ast
Role of bisphosphonates in prostate cancer bone metastases.
@en
prefLabel
Role of bisphosphonates in prostate cancer bone metastases.
@ast
Role of bisphosphonates in prostate cancer bone metastases.
@en
P1433
P1476
Role of bisphosphonates in prostate cancer bone metastases.
@en
P2093
John M Chirgwin
P304
P356
10.1016/S0093-7754(03)00347-6
P577
2003-10-01T00:00:00Z